Search - tctmd.com

Displaying 201 - 220 of 1571

Sort: Relevancy | Date

Presentation THT 2025

Optimizing Outcomes in Cardiac Arrest and Shock

Presenter: Jacqueline Tamis-Holland

February 11, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Hemodynamic Effects of Intravenous Istaroxime in Patients With SCAI Stage B Cardiogenic Shock: Insights From the SEISMiC Trial

Presenter: Matteo Pagnesi

February 11, 2025

Presentation THT 2025

Only Select Patients Should Have a PA Pressure Sensor

Presenter: Maria Rosa Costanzo

February 11, 2025

Presentation THT 2025

All NYHA III Patients Should Have a PA Pressure Sensor

Presenter: Michael Givertz

February 11, 2025

Presentation THT 2025

Preserving Access: Limiting the Use of Advanced Therapies

Presenter: Gerin Stevens

February 11, 2025

Presentation THT 2025

Increasing Access: Using Team-Based Care to Get STRONG

Presenter: Laura Cohen

February 11, 2025

Presentation THT 2025

Evidence Is Getting STRONGer That Rapid GDMT Uptitration After an AHF Event Is Effective Regardless of LVEF

Presenter: Gad Cotter

February 11, 2025

Presentation THT 2025

Increasing Reach: Using TeleHealth to Get STRONGer

Presenter: Daniel Bensimhon

February 11, 2025

Presentation THT 2025

Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients

Presenter: Nir Uriel

February 11, 2025

Presentation Controversies and Advances 2025

The Good, the Bad and the Ugly of Clinical Trial Design

Presenter: Stuart Pocock

January 31, 2025

Presentation Miami Valves 2025

Clinical Trials for Mitral Regurgitation Beyond TEER: Where to Next

Presenter: Jeffrey Popma

January 30, 2025

Presentation Miami Valves 2025

Clinical Trials Propel TAVR Forward

Presenter: Jeffrey Popma

January 30, 2025

Presentation AHA 2024

Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks

Presenter: Steven E. Nissen

November 18, 2024

Presentation AHA 2024

Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial

Presenter: Marcely Gimenes Bonatto

November 18, 2024

Presentation AHA 2024

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Presenter: Kausik K. Ray

November 17, 2024

Presentation AHA 2024

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Presenter: Milton Packer

November 16, 2024

Presentation TCT 2024

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Presenter: Lei Song

October 30, 2024

Presentation TCT 2024

Patient-Reported Outcomes are a True Measure of TTVI Value

Presenter: John Spertus

October 30, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH)

Presenter: Jung-Min Ahn

October 30, 2024

Advertisement

Optimizing Outcomes in Cardiac Arrest and Shock

Special Late-Breaking Clinical Science Abstract: Hemodynamic Effects of Intravenous Istaroxime in Patients With SCAI Stage B Cardiogenic Shock: Insights From the SEISMiC Trial

Only Select Patients Should Have a PA Pressure Sensor

All NYHA III Patients Should Have a PA Pressure Sensor

Preserving Access: Limiting the Use of Advanced Therapies

Increasing Access: Using Team-Based Care to Get STRONG

Evidence Is Getting STRONGer That Rapid GDMT Uptitration After an AHF Event Is Effective Regardless of LVEF

Increasing Reach: Using TeleHealth to Get STRONGer

Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients

The Good, the Bad and the Ugly of Clinical Trial Design

Clinical Trials for Mitral Regurgitation Beyond TEER: Where to Next

Clinical Trials Propel TAVR Forward

Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks

Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Patient-Reported Outcomes are a True Measure of TTVI Value

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content